Yuqiang Mi
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.
Journal: The American journal of gastroenterology
Published: January 19, 2026
Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0.
Journal: The American journal of gastroenterology
Published: January 19, 2026
ACT001 alleviates MASLD through gut microbiota-bile acid-FXR axis in mice.
Journal: Annals of medicine
Published: November 06, 2025
The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B.
Journal: Frontiers in immunology
Published: September 19, 2025
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: April 23, 2025
Development and validation of a modified PAGE-B score based nomogram for predicting hepatocellular carcinoma in antiviral-treated chronic hepatitis B patients with metabolic dysfunction.
Journal: BMC infectious diseases
Published: April 20, 2025
A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice.
Journal: Frontiers in medicine
Published: April 11, 2025
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis.
Journal: Hepatology (Baltimore, Md.)
Published: February 04, 2025
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD.
Journal: Journal of hepatology
Published: January 24, 2025
Olaparib reverses prostate cancer resistance to Rapamycin by promoting macrophage polarization towards the M1 phenotype.
Journal: Molecular and cellular biochemistry
Published: November 06, 2024
Last Updated: 09/26/2026